By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal third 2024 results along with program updates, progress in its GLP-1 trials, a capital raise and final preparations for the Phase Ib trial evaluating DehydraTECH in obese patients. Several new patents were granted bringing the total to 43. … Read more
This post is part of a series sponsored by Darkhorse Insurance. Having to start an agency is an exciting and rewarding venture, but it’s crucial to plan for the financial commitments involved. From initial setup costs to ongoing expenses, understanding these financial realities will empower you to make informed decisions and set your agency up … Read more
Moby Finance should be on your radar if you want to streamline your investing tasks. This investment research platform provides easy-to-understand data that you can use to make challenging investment decisions. Check out my Moby Finance review to see what it’s all about. What Is Moby Finance? Moby Finance offers stock and crypto investment research … Read more
For over a decade, we have pretended to be paperless. We tout the fact that the file cabinets, the 7-part specialized file folders, and massive mail rooms have all been eliminated and reduced, and claim that we are paperless. But we know it isn’t real. Today’s paper is PDFs, excels, and adobe. The filing cabinets … Read more
Do you want to learn how to start a personal finance blog? Starting a personal finance blog changed my life. When I began Making Sense of Cents (the blog that you’re reading right now!), I had no idea that sharing my money tips would lead to financial freedom and the ability to work from anywhere…. … Read more